Table 8.

In-vitro cytotoxicity of synthesized compounds against Breast cancer cell line (MCF-7) [51]

Compound	% Viability
	6.25 μg/ml	12.5 μg/ml	25 μg/ml	50 μg/ml	100 μg/ml
11a	38.04	37.15	39.68	35.11	40.31
11b	38.26	42.70	37.90	38.84	43.24
11c	44.35	41.6	41.81	39.64	37.24
11d	42.70	39.46	40.48	37.61	37.37
11e	30.60	32.20	34.48	33.86	37.54
11f	32.57	33.09	30.88	30.75	24.87
11 g	34.39	33.58	28.80	32.40	30.96
11 h	32.03	35.40	31.25	33.69	34.45

Control % viability = 100